#top-leaderboard-ads, .stickyads { position: static !important; }

Can you describe a patient who was reluctant to undergo field therapy again after a difficult previous experience and how tirbanibulin affected your treatment approach?

Name: Can you describe a patient who was reluctant to undergo field therapy again after a difficult previous experience and how tirbanibulin affected your treatment approach?
Uploaded: 2026-10-01T00:00:00.000Z
Description: Can you describe a patient who was reluctant to undergo field therapy again after a difficult previous experience and how tirbanibulin affected your treatment approach?

Featuring:

ADAndrew Dorizas, MD

Updated:Oct 1, 2026

Actinic Keratosis

Can you describe a patient who was reluctant to undergo field therapy again after a difficult previous experience and how tirbanibulin affected your treatment approach?

About this video